The company " Immuno-Hem" is engaged in the development and production of drugs from blood plasma, the main of which is "Gabreglobine" (human normal immunoglobulin for intravenous administration).
The company was established in 1999 on the basis of "The Moscow research Institute of epidemiology and microbiology named after G. N. Gabrichevsky" for industrial implementation of the results of scientific discoveries.
Until 2003, the company was engaged in the production of probiotics in tablet form.
At the same time, under the leadership of Professor A. G. Lyutov, the organization conducted scientific research and clinical research on new drugs. Thus, together with the G. N. Gabrichevsky Moscow state medical Institute, the drugs "Gabreglobine" and the immunoglobulin complex drug were developed and patented.